参考文献/References:
[1] CHATTOPADHYAY C,KIM D W,GOMBOS D S,OBA J,QIN Y,WILLIAMS M D,et al.Uveal melanoma: From diagnosis to treatment and the science in between[J].Cancer,2016,122(15):2299-2312.
[2] MANIOTIS A J,FOLBERG R,HESS A,SEFTOR E A,GARDNER L M,PEER J,et al.Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry[J].Am J Pathol,1999,155(3):739-752.
[3] QIAO L,LIANG N,ZHANG J,XIE J,LIU F,XU D, et al.Advanced research on vasculogenic mimicry in cancer[J].J Cell Mol Med,2015,19(2):315-326.
[4] ZHANG B,YU X,XIA H.The flavonoid luteolin enhances doxorubicin-induced autophagy in human osteosarcoma U2OS cells[J].Int J Clin Exp Med,2015,8(9):15190-15197.
[5] LUO Y,SHANG P,LI D.Luteolin: A flavonoid that has multiple cardio-protective effects and its molecular mechanisms[J].Front Pharmacol,2017,8:692.
[6] ZHANG J X,XING J G,WANG L L,JIANG H L,GUO S L,LIU R.Luteolin inhibits fibrillary beta-amyloid1-40-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-kappaB signaling pathways[J].Molecules,2017,22(3):334.
[7] ZANG M,HU L,ZHANG B,ZHU Z,LI J,ZHU Z,et al.Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer[J].Biochem Biophys Res Commun,2017,490(3):913-919.
[8] 平晓芳,崔锡梅,陈伟,邢卫斌.木犀草素对黑素瘤B16细胞系生长、转移及血管生成拟态形成的抑制作用研究[J].中华皮肤科杂志,2019,52(6):401-407.
PING X F,CUI X M,CHEN W,XING W B.Inhibitory effect of luteolin on the growth,migration and vasculogenic mimicry formation of a melanoma cell line B16[J].Chin J Dermatol,2019,52(6):401-407.
[9] SHERBET G V.Therapeutic potential of thalidomide and its analogues in the treatment of cancer[J].Anticancer Res,2015,35(11):5767-5772.
[10] LIU K,SUN B,ZHAO X,WANF X,LI Y,QIU Z,et al.Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma[J].Int J Mol Med,2015,36(3):783-791.
[11] FAN Y L,ZHENG M,TANG Y L,LIANG X H.A new perspective of vasculogenic mimicry: EMT and cancer stem cells[J].Oncol Lett,2013,6(5):1174-1180.
[12] 高文,陈陆霞,何彦津.人脉络膜黑色素瘤细胞株OCM-1的三维培养及血管生成拟态机制的研究[J].眼科新进展,2017,37(9):828-831.
GAO W,CHEN L X,HE Y J.Research on 3-dimentional culture of human choroidal melanoma cell line (OCM-1) in vitro and the mechanism of vasculogenic mimicry[J].Rec Adv Ophthalmol, 2017,37(9):828-831.
[13] RACORDON D,VALDIVIA A,MINGO G,ERICES R,ARAVENA R,SANTORO F,et al.Structural and functional identification of vasculogenic mimicry in vitro[J].Sci Rep,2017,7(1):6985.
[14] 安芳玲,和祯泉,马芳,扈一楠,顾金海.CXCL8/PI3K-Akt信号通路在缺氧诱导的人脑胶质瘤细胞血管生成拟态中的作用[J].中国老年学杂志,2016,36(10):2312-2315.
AN F L,HE Z Q,MA F,HU Y N,GU J H.Roles of CXCL8/PI3K-Akt signaling pathway in vascular mimicry induced by hypoxia of human glioma cell line U87MG and U251[J].Chin J Gerontol,2016,36(10):2312-2315.
[15] ZHANG X,SONG Q,WEI C Y,QU J Q.LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells[J].Cell Stress Chaperon,2015,20(4):631-641.
相似文献/References:
[1]高文,何彦津.姜黄素对人脉络膜黑色素瘤细胞株OCM-1血管生成拟态形态学和病理改变的影响[J].眼科新进展,2017,37(1):027.[doi:10.13389/j.cnki.rao.2017.0007]
GAO Wen,HE Yan-Jin.Effects of curcumin on pathological and morphological changes of vasculogenic mimicry in choroid melanoma cell line OCM-1[J].Recent Advances in Ophthalmology,2017,37(8):027.[doi:10.13389/j.cnki.rao.2017.0007]
[2]高敏,唐金华,刘海芸.超声造影对兔眼脉络膜黑色素瘤血流循环的定量评估[J].眼科新进展,2017,37(11):1005.[doi:10.13389/j.cnki.rao.2017.0255]
GAO Min,TANG Jin-Hua,LIU Hai-Yun.Quantitative evaluation of microcirculation in choroidal melanoma of rabbits using contrast-enhanced ultrasound[J].Recent Advances in Ophthalmology,2017,37(8):1005.[doi:10.13389/j.cnki.rao.2017.0255]
[3]高文,陈陆霞,何彦津,等.姜黄素对人脉络膜黑色素瘤细胞株血管形成拟态抑制作用及其相关机制的研究[J].眼科新进展,2017,37(11):1018.[doi:10.13389/j.cnki.rao.2017.0258]
GAO Wen,CHEN Lu-Xia,HE Yan-Jin,et al.Inhibitory effects of curcumin on vasculogenic mimicry in choroid melanoma cell line OCM-1 and its mechanisms[J].Recent Advances in Ophthalmology,2017,37(8):1018.[doi:10.13389/j.cnki.rao.2017.0258]
[4]任耘,蔡明高,霍鸣.胰岛素样生长因子1受体(IGF-1R)基因表达对脉络膜黑色素瘤细胞增殖、凋亡及STAT3信号通路的调控作用[J].眼科新进展,2018,38(11):1024.[doi:10.13389/j.cnki.rao.2018.0241]
REN Run,CAI Ming-Gao,HUO Ming.IGF-1R gene expression inhibits the proliferation and promotes apoptosis of choroidal melanoma through inhibition of STAT3 signaling pathway[J].Recent Advances in Ophthalmology,2018,38(8):1024.[doi:10.13389/j.cnki.rao.2018.0241]
[5]燕玉清,赵红.脉络膜黑色素瘤的病理特点与预后[J].眼科新进展,2019,39(1):075.[doi:10.13389/j.cnki.rao.2019.0017]
YAN Yu-Qing,ZHAO Hong.The pathological characteristics and prognosis of choroid melanoma[J].Recent Advances in Ophthalmology,2019,39(8):075.[doi:10.13389/j.cnki.rao.2019.0017]
[6]方健文,袁晴,邵毅.人源性肿瘤异种移植模型在眼科的应用进展[J].眼科新进展,2019,39(7):695.[doi:10.13389/j.cnki.rao.2019.0160]
FANG Jian-Wen,YUAN Qing,SHAO Yi.Application progress of patient-derived xenograft model(PDX) in ophthalmology[J].Recent Advances in Ophthalmology,2019,39(8):695.[doi:10.13389/j.cnki.rao.2019.0160]
[7]魏达亨,孙丽丽,何慧君,等.木犀草素对碘酸钠诱导的视网膜色素上皮细胞及视网膜损伤的保护作用[J].眼科新进展,2019,39(9):814.[doi:10.13389/j.cnki.rao.2019.0185]
WEI Da-Heng,SUN Li-Li,HE Hui-Jun,et al.Protective effect of luteolin against damage to retinal pigment epithelial cells and retina induced by sodium iodate[J].Recent Advances in Ophthalmology,2019,39(8):814.[doi:10.13389/j.cnki.rao.2019.0185]
[8]李茜,王红星,傅强,等.木犀草素对视网膜缺血-再灌注损伤(RIRI)大鼠TLR4/Syk/NF-κB信号通路及视网膜的影响[J].眼科新进展,2021,41(4):311.[doi:10.13389/j.cnki.rao.2021.0065]
LI Qian,WANG Hongxing,FU Qiang,et al.Effects of luteolin on TLR4/Syk/NF-κB signaling pathway and retina in rats with retinal ischemia-reperfusion injury[J].Recent Advances in Ophthalmology,2021,41(8):311.[doi:10.13389/j.cnki.rao.2021.0065]
[9]石丽娟,李丽,石福艳,等.基于倾向性评分逆概率加权法的脉络膜黑色素瘤患者疗效评价研究[J].眼科新进展,2023,43(4):308.[doi:10.13389/j.cnki.rao.2023.0063]
SHI Lijuan,LI Li,SHI Fuyan,et al.Efficacy evaluation of choroidal melanoma based on propensity score inverse probability of treatment weighting method[J].Recent Advances in Ophthalmology,2023,43(8):308.[doi:10.13389/j.cnki.rao.2023.0063]
[10]陈慈民,张雨,陈美玲,等.木犀草素与青蒿琥酯联合用药防治实验性外伤性增生性玻璃体视网膜病变[J].眼科新进展,2023,43(9):680.[doi:10.13389/j.cnki.rao.2023.0137]
CHEN Cimin,ZHANG Yu,CHEN Meiling,et al.Prevention and treatment of experimental traumatic proliferative vitreoretinopathy with luteolin and artesunate[J].Recent Advances in Ophthalmology,2023,43(8):680.[doi:10.13389/j.cnki.rao.2023.0137]